Stay updated with breaking news from Seraxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Synthetic Replacement Endocrine (SRE) Clusters GERMANTOWN, Md., April 25, 2023 (Newswire.com) - Seraxis Inc., a pre-clinical stage company with a best-in-class islet replacement therapy for insulin-dependent diabetes, today announced the presentation of results from an ef...
Seraxis Presents Successful Results Using Synthetic Replacement Endocrine ...
Stem Cell Therapy Market Research Report Information By Cell Source (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood-Derived, IPSCs, PPSCs), By
Chronic health conditions, including heart disease, neurological disorders, cancer, respiratory illnesses, stroke, and cardiovascular disorders, are...
/PRNewswire/ -- The regenerative medicine company Seraxis today announces that Shelley Hartman, Jerry Baty, and Min-Jung Choi are appointed to its Board of...